MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vyas, K. P.
Right arrow Articles by Jerina, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vyas, K. P.
Right arrow Articles by Jerina, D. M.

Regioselectivity and stereoselectivity in the metabolism of trans-1,2- dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes

KP Vyas, PJ van Bladeren, DR Thakker, H Yagi, JM Sayer, W Levin and DM Jerina

Metabolism of [3H]-(+/-)-trans-1,2-dihydroxy-1,2-dihydrobenz[a] anthracene by liver microsomes isolated from control, phenobarbital- treated, and 3-methylcholanthrene-treated Long-Evans rats and from 3- methylcholanthrene-treated Sprague-Dawley rats was examined. Liver microsomes from both control and phenobarbital-treated rats metabolized the dihydrodiol at a rate of 0.5 nmol/nmole of cytochrome P450 per minute, whereas prior treatment of rats with 3-methylcholanthrene stimulated the rate of metabolism by 4-fold. Prior treatment of the rats caused marked differences in the regio- and stereoselectivity of the metabolism of this pseudo-diaxial dihydrodiol. In each case, the major metabolites were three bis-dihydrodiols and a pair of diastereomeric 1,2-diol-3,4-epoxides in which the benzylic 1-hydroxyl group is either cis or trans to the epoxide oxygen (diol epoxides-1 and -2, respectively). The presence of the diol epoxides in the incubation medium was inferred from the identification of their corresponding tetraols, which arise by hydrolysis of the diol epoxides on chromatography. Hepatic microsomes from control and phenobarbital- treated rats metabolized the 1,2-dihydrodiol predominantly to 1,2-diol- 3,4-epoxides (68-85% of the total metabolites) whereas bis-dihydrodiols represented 28% and 13% of the total metabolites, respectively. In contrast, liver microsomes from 3-methylcholanthrene-treated rats of either strain metabolized the 1,2-dihydrodiol primarily to isomeric bis- dihydrodiols (51-56% of total metabolites), with diol epoxides accounting for only 36-38% of the total metabolites. Bis-dihydrodiol-1 (32-35% of the total metabolites) was formed in greater amounts (2- to 4-fold) than either bis-dihydrodiols-2 or -3, which were formed in about equal amounts and have identical absorption spectra. The ratio of the diastereomeric 1,2-diol-3,4-epoxides-1 and -2 was highly dependent upon the preparation used. For microsomes from control and phenobarbital-treated rats, this ratio was between 3:1 and 4:1 whereas microsomes from 3-methylcholanthrene-treated rats (greater than 70% cytochrome P-450c) gave a ratio of between 1:1.5 and 1:2. The basis for this ratio in the latter case was explained by examination of the products formed from the (+)-(1S,2S)-and (-)-(1R,2R)-enantiomers of the dihydrodiol on metabolism by a highly purified system reconstituted with cytochrome P-450c. The (-)-isomer is a 3-fold better substrate than the (+)-isomer and forms only the diol epoxide-2 diastereomer, whereas the (+)-isomer forms much more diol epoxide-1 than diol epoxide- 2 diastereomer.

Volume 24, Issue 1, pp. 115-123, 07/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Luch, S. Kishiyama, A. Seidel, J. Doehmer, H. Greim, and W. M. Baird
The K-Region trans-8,9-Diol Does Not Significantly Contribute as an Intermediate in the Metabolic Activation of Dibenzo[a,l]pyrene to DNA-binding Metabolites by Human Cytochrome P450 1A1 or 1B1
Cancer Res., September 1, 1999; 59(18): 4603 - 4609.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics